An advisory, issued by Information and Broadcasting (I&B) Ministry Director (Broadcasting) Amit Katoch said the channels should advertise only those products and drugs that have valid licences, failure of which will attract action.
The move comes after the AYUSH Ministry approached the I&B Ministry, saying some channels were carrying advertisements with "exaggerated or improper claims" of such drugs.
Also Read
The advisory said the misleading advertisements of these products and drugs are in violation of the Drug and Magic Remedies (Objectionable Advertisements) Act 1954, and Drugs and Cosmetic Act 1940.
"... In order to protect the citizens from misleading advertisement and health risk, all TV channels are hereby advised to ensure strict compliance of provisions of the Drug and Magic Remedies (Objectionable Advertisements) Act 1954 and Drug and Cosmetic Act 1940 as amended from time to time," the advisory read.
It said these rules should be adhered to "in letter and spirit" while telecasting advertisements on TV channels.
"TV channels are advised to advertise only products that have valid licence issued by Ministry of AYUSH or state drug licensing authorities. Any failure will attract action...," the advisory said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)